Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
https://www.alvarezandmarsal.com/insights/is-omicron-our-way-out
Part I: A look at HHS, the Latest COVID-19 Relief Bill and What the Next Two Years Means for Democrats and Republicans In this...
The rise in cybersecurity attacks throughout the pandemic has been felt across the healthcare industry. Healthcare organizations have had to pivot their cybersecurity strategies...
Hospital, physician and other healthcare provider recipients of the CARES Act funding, must be careful to conduct effective diligence and demonstrate compliance with funding...
